Total Liabilities Summary of HANDOK Inc.

HANDOK Inc.'s latest annual total liabilities in 2023 was 449.7 Billion KRW , down -8.08% from previous year.
HANDOK Inc.'s latest quarterly total liabilities in 2024 Q2 was 456.31 Billion KRW , down -4.04% from previous quarter.
HANDOK Inc. reported annual total liabilities of 489.25 Billion KRW in 2022, up 6.92% from previous year.
HANDOK Inc. reported annual total liabilities of 457.56 Billion KRW in 2021, up 4.69% from previous year.
HANDOK Inc. reported quarterly total liabilities of 456.31 Billion KRW for 2024 Q2, down -4.04% from previous quarter.
HANDOK Inc. reported quarterly total liabilities of 449.7 Billion KRW for 2023 Q4, down -4.78% from previous quarter.

Annual Total Liabilities Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Total Liabilities of HANDOK Inc. (2023 - 2007)

Year	Total Liabilities	Total Liabilities Growth
2023	449.7 Billion KRW	-8.08%
2022	489.25 Billion KRW	6.92%
2021	457.56 Billion KRW	4.69%
2020	437.07 Billion KRW	8.01%
2019	404.67 Billion KRW	19.29%
2018	339.24 Billion KRW	-2.69%
2017	348.63 Billion KRW	4.51%
2016	333.59 Billion KRW	47.04%
2015	226.88 Billion KRW	9.23%
2014	207.71 Billion KRW	15.88%
2013	179.25 Billion KRW	20.19%
2012	149.14 Billion KRW	14.83%
2011	129.87 Billion KRW	16.33%
2010	111.64 Billion KRW	0.31%
2009	111.3 Billion KRW	3.55%
2008	107.48 Billion KRW	5.5%
2007	101.88 Billion KRW	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	475.54 Billion KRW	5.75%
2024 Q2	456.31 Billion KRW	-4.04%
2023 Q4	449.7 Billion KRW	-4.78%
2023 Q1	494.62 Billion KRW	1.1%
2023 Q3	472.29 Billion KRW	-1.35%
2023 Q2	478.73 Billion KRW	-3.21%
2023 FY	449.7 Billion KRW	-8.08%
2022 Q1	496.66 Billion KRW	8.55%
2022 Q2	457.69 Billion KRW	-7.85%
2022 FY	489.25 Billion KRW	6.92%
2022 Q4	489.25 Billion KRW	-0.88%
2022 Q3	493.59 Billion KRW	7.84%
2021 Q2	507.55 Billion KRW	12.74%
2021 Q3	461.22 Billion KRW	-9.13%
2021 FY	457.56 Billion KRW	4.69%
2021 Q1	450.18 Billion KRW	3.0%
2021 Q4	457.56 Billion KRW	-0.79%
2020 Q4	437.07 Billion KRW	-2.05%
2020 FY	437.07 Billion KRW	8.01%
2020 Q1	424.2 Billion KRW	4.83%
2020 Q3	446.24 Billion KRW	-4.2%
2020 Q2	465.8 Billion KRW	9.81%
2019 Q2	362.12 Billion KRW	-0.4%
2019 FY	404.67 Billion KRW	19.29%
2019 Q4	404.67 Billion KRW	4.92%
2019 Q3	385.7 Billion KRW	6.51%
2019 Q1	363.56 Billion KRW	7.17%
2018 Q1	333.86 Billion KRW	-4.24%
2018 Q4	339.24 Billion KRW	2.98%
2018 Q3	329.41 Billion KRW	-2.85%
2018 FY	339.24 Billion KRW	-2.69%
2018 Q2	339.06 Billion KRW	1.56%
2017 Q2	342.91 Billion KRW	1.02%
2017 Q3	398.15 Billion KRW	16.11%
2017 Q4	348.63 Billion KRW	-12.44%
2017 FY	348.63 Billion KRW	4.51%
2017 Q1	339.44 Billion KRW	1.75%
2016 Q1	246.62 Billion KRW	8.7%
2016 Q3	277.27 Billion KRW	2.36%
2016 Q4	333.59 Billion KRW	20.31%
2016 FY	333.59 Billion KRW	47.04%
2016 Q2	270.88 Billion KRW	9.83%
2015 FY	226.88 Billion KRW	9.23%
2015 Q4	226.88 Billion KRW	0.0%
2014 Q1	237.77 Billion KRW	32.65%
2014 FY	207.71 Billion KRW	15.88%
2014 Q2	213.81 Billion KRW	-10.07%
2014 Q3	215 Billion KRW	0.55%
2013 Q1	163.82 Billion KRW	9.84%
2013 Q3	173.42 Billion KRW	5.49%
2013 Q4	179.25 Billion KRW	3.36%
2013 FY	179.25 Billion KRW	20.19%
2013 Q2	164.39 Billion KRW	0.35%
2012 Q4	149.14 Billion KRW	0.0%
2012 FY	149.14 Billion KRW	14.83%
2012 Q1	133.41 Billion KRW	0.0%
2011 FY	129.87 Billion KRW	16.33%
2011 Q3	140.28 Billion KRW	17.53%
2011 Q2	119.36 Billion KRW	1.06%
2011 Q1	118.1 Billion KRW	5.79%
2010 Q4	111.64 Billion KRW	-25.13%
2010 FY	111.64 Billion KRW	0.31%
2010 Q2	137.01 Billion KRW	20.58%
2010 Q3	149.11 Billion KRW	8.83%
2010 Q1	113.62 Billion KRW	2.09%
2009 Q3	99.97 Billion KRW	0.72%
2009 Q2	99.26 Billion KRW	-2.22%
2009 Q4	111.3 Billion KRW	11.33%
2009 Q1	101.51 Billion KRW	-5.56%
2009 FY	111.3 Billion KRW	3.55%
2008 Q2	101.95 Billion KRW	2.68%
2008 Q1	99.29 Billion KRW	-2.54%
2008 Q3	103.25 Billion KRW	1.28%
2008 FY	107.48 Billion KRW	5.5%
2008 Q4	107.48 Billion KRW	4.09%
2007 Q2	83.69 Billion KRW	4.32%
2007 Q1	80.22 Billion KRW	0.0%
2007 Q3	94.27 Billion KRW	12.65%
2007 FY	101.88 Billion KRW	0.0%
2007 Q4	101.88 Billion KRW	8.07%

Peer Total Liabilities Comparison of HANDOK Inc.

Name	Total Liabilities	Total Liabilities Difference
Yuyu Pharma, Inc.	77.85 Billion KRW	-477.599%
Dong-A Socio Holdings Co., Ltd.	929.79 Billion KRW	51.634%
Ildong Holdings Co., Ltd.	707.09 Billion KRW	36.401%
Kukje Pharma Co., Ltd.	85.67 Billion KRW	-424.927%
Yuhan Corporation	712.33 Billion KRW	36.869%
Dong-A ST Co., Ltd.	631.91 Billion KRW	28.834%
SAMSUNG PHARM. Co., LTD.	15.89 Billion KRW	-2729.324%
Hanmi Pharm. Co., Ltd.	851.82 Billion KRW	47.207%
Hanall Biopharma Co.,Ltd	53.52 Billion KRW	-740.123%
Ilyang Pharmaceutical Co.,Ltd	205.87 Billion KRW	-118.436%
Dong Sung Bio Pharm.Co.,Ltd.	75.17 Billion KRW	-498.245%
MYUNGMOON Pharm co.,Ltd	147.79 Billion KRW	-204.279%
Hana Pharm Co., Ltd.	70.4 Billion KRW	-538.776%
Yuyu Pharma, Inc.	77.85 Billion KRW	-477.599%
Ilsung Pharmaceuticals Co., Ltd.	36.43 Billion KRW	-1134.228%
REYON Pharmaceutical Co., Ltd.	251.15 Billion KRW	-79.058%
Aprogen pharmaceuticals,Inc.	220.7 Billion KRW	-103.759%
JW Holdings Corporation	827.51 Billion KRW	45.656%
Ildong Pharmaceutical Co., Ltd.	436.99 Billion KRW	-2.909%
Chong Kun Dang Pharmaceutical Corp.	586.79 Billion KRW	23.362%
JW Pharmaceutical Corporation	379.59 Billion KRW	-18.469%
Shin Poong Pharm.Co.,Ltd.	79.3 Billion KRW	-467.085%
Hyundai Pharmaceutical Co., Ltd.	69.96 Billion KRW	-542.735%
Samil Pharmaceutical Co.,Ltd	242.85 Billion KRW	-85.177%
Jeil Pharmaceutical Co.,Ltd	330.29 Billion KRW	-36.153%
Yuyu Pharma, Inc.	77.85 Billion KRW	-477.599%
Kwang Dong Pharmaceutical Co., Ltd.	490.01 Billion KRW	8.227%
Daewoong pharmaceutical Co.,Ltd	858.02 Billion KRW	47.588%
JW Pharmaceutical Corporation	379.59 Billion KRW	-18.469%
Yuhan Corporation	712.33 Billion KRW	36.869%
Jeil Pharma Holdings Inc	477.81 Billion KRW	5.882%
Yungjin Pharm. Co., Ltd.	136.96 Billion KRW	-228.328%
Suheung Co., Ltd.	516.66 Billion KRW	12.96%
JW Pharmaceutical Corporation	379.59 Billion KRW	-18.469%
Samjin Pharmaceuticals Co., Ltd.	154.53 Billion KRW	-191.004%
Korea United Pharm Inc.	89.96 Billion KRW	-399.867%
CKD Bio Corp.	170.76 Billion KRW	-163.355%
Daewon Pharmaceutical Co., Ltd.	243.73 Billion KRW	-84.507%
Dongwha Pharm.Co.,Ltd	157.65 Billion KRW	-185.244%
Whan In Pharm Co.,Ltd.	43.01 Billion KRW	-945.364%
Shin Poong Pharm.Co.,Ltd.	79.3 Billion KRW	-467.085%
Chong Kun Dang Holdings Corp.	632.51 Billion KRW	28.902%
Boryung Corporation	373.1 Billion KRW	-20.53%
Bukwang Pharmaceutical Co., Ltd.	208.19 Billion KRW	-116.0%
Ilyang Pharmaceutical Co.,Ltd	205.87 Billion KRW	-118.436%
JW Lifescience Corporation	96.44 Billion KRW	-366.291%

Global Stocks Search

HANDOK Inc. (002390.KS)

Total Liabilities Summary of HANDOK Inc.

Annual Total Liabilities Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Total Liabilities of HANDOK Inc. (2023 - 2007)

Peer Total Liabilities Comparison of HANDOK Inc.